Synopsis of recent research by authors named "Khaled Alayed"
- Khaled Alayed's recent research primarily focuses on the identification and characterization of specific immune cell markers and genetic mutations in various hematologic malignancies, particularly myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
- He has demonstrated that CD177-positive neutrophils serve as a significant flow cytometry marker for the diagnosis of MDS, and his studies have explored the association between CD177 levels and various somatic mutations such as NPM1, RUNX1, TET2, and U2AF1 S34F.
- Alayed's work also investigates other hematological conditions like plasmablastic lymphoma and Langerhans cell histiocytosis, providing insights into the genetic underpinnings of these diseases and improving diagnostic methodologies through advanced flow cytometric techniques.
